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Abstract
Background: The symptom profile and neuropsychological functioning of individuals with Attention Deficit/
Hyperactivity Disorder (ADHD), change as they enter adolescence. It is unclear whether variation in brain structure and
function parallels these changes, and also whether deviations from typical brain development trajectories are associated
with differential outcomes. This paper describes the Neuroimaging of the Children’s Attention Project (NICAP), a
comprehensive longitudinal multimodal neuroimaging study. Primary aims are to determine how brain structure and
function change with age in ADHD, and whether different trajectories of brain development are associated with
variations in outcomes including diagnostic persistence, and academic, cognitive, social and mental health outcomes.
Methods/Design: NICAP is a multimodal neuroimaging study in a community-based cohort of children with and
without ADHD. Approximately 100 children with ADHD and 100 typically developing controls will be scanned at a
mean age of 10 years (range; 9–11years) and will be re-scanned at two 18-month intervals (ages 11.5 and 13 years
respectively). Assessments include a structured diagnostic interview, parent and teacher questionnaires, direct child
cognitive/executive functioning assessment and magnetic resonance imaging (MRI). MRI acquisition techniques,
collected at a single site, have been selected to provide optimized information concerning structural and functional
brain development.
Discussion: This study will allow us to address the primary aims by describing the neurobiological development of
ADHD and elucidating brain features associated with differential clinical/behavioral outcomes. NICAP data will also be
explored to assess the impact of sex, ADHD presentation, ADHD severity, comorbidities and medication use on brain
development trajectories. Establishing which brain regions are associated with differential clinical outcomes, may allow
us to improve predictions about the course of ADHD.
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Background
Attention-deficit/hyperactivity disorder (ADHD) is one of
the most common neurodevelopmental disorders of child-
hood, affecting 5 % of school-age children [1]. ADHD has
a major impact on everyday functioning, with affected
children experiencing significant and lasting impairments
across multiple domains including mental health, aca-
demic, cognitive, social, and family functioning [2–5].
Although 30–40 % of affected children show a reduction
of symptoms in adolescence [6], related impairments are
enduring [2, 3] and are associated with increased risk of
poor academic achievement and early school dropout, in-
creased rates of criminality, substance abuse and mental
health disorders [7].
The Children’s Attention Project (CAP) [8] is an
Australian longitudinal study of community-based chil-
dren with ADHD and non-ADHD controls, mapping the
developmental course of ADHD symptoms, and identify-
ing risk and protective factors associated with differential
outcomes. It is tracking an extremely well-phenotyped
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sample assessed at mean ages 7, 8.5, and 10 years. Data
are collected on current ADHD status, comorbidities, key
functional domains relevant to ADHD (mental health,
cognitive, academic and social functioning), medication
use, and general wellbeing.
This paper describes the Neuroimaging of the Children’s
Attention Project (NICAP). This extension to CAP in-
volves comprehensive longitudinal multimodal neuroim-
aging to determine how brain structure and function
change over developmental stages in ADHD, and whether
deviations from typical trajectories of brain development
are associated with differential outcomes, such as the per-
sistence or remission of ADHD symptoms and academic,
cognitive, social and mental health outcomes. This paper
describes the rationale, design and methodology of the
neuroimaging protocol for NICAP.
ADHD and the developing adolescent brain
As individuals enter adolescence, the presentation of
some ADHD symptoms and neuropsychological func-
tioning appears to change [9–12]. Inattentive symptoms
remain relatively constant from ages 9–12 years, whereas
hyperactive/impulsive symptoms decline although they
do not normalize [13, 14]. The transition to adolescence
is an important developmental shift with major environ-
mental and biological changes potentially exerting influ-
ence on functional status. This includes the transition to
high school which has been associated with an interrup-
tion in the decline in ADHD symptomotology [9]. It also
corresponds with the major physiological and emotional
effects of puberty.
Numerous cross-sectional studies have examined brain
differences between individuals with and without ADHD.
Functional imaging studies have highlighted several ab-
normalities in individuals with ADHD, particularly in the
prefrontal cortex and striatum (fronto-striatal circuits)
and the parietal cortex [15–19]. Structural imaging studies
have reported ADHD-related anomalies in the prefrontal
cortex, cerebellum, striatum and basal ganglia, corpus
callosum, and the parietal cortex [20–27]. There is debate
as to whether these differences represent specific brain
abnormalities characteristic of ADHD, or a delay of nor-
mal development (i.e., a maturation lag) [28]. However,
there have been marked inconsistencies in previous stud-
ies, attributable to the use of small, homogenous clinical
samples with considerable between-study variation in sub-
types, gender and age. Generalizability to the larger/wider
population of children with ADHD is therefore limited.
While ADHD symptoms vary considerably with age and
neuroimaging abnormalities have been described in chil-
dren with ADHD, it is unclear whether the changes in
brain structure and function parallel symptom changes. It
is also unknown whether deviations from typical trajector-
ies of brain development are associated with differential
outcomes, such as the persistence or remission of ADHD
symptoms and academic, cognitive, social and mental
health outcomes. A recent meta-analysis [29], identified the
need for longitudinal designs and larger samples to advance
the field. For our understanding of the neural underpin-
nings of ADHD to progress and generate knowledge that
will inform treatments, there is a need to establish working
models of neurodevelopment. This can best be achieved by
linking serial measures of brain development, using mul-
tiple state-of-the-art neuroimaging methods, with detailed
phenotypic and functional outcomes indices.
NICAP will collect single site, multimodal neuroimag-
ing on a high-resolution 3 Tesla scanner to link neuro-
biological structure and function to academic, cognitive,
social, and mental health outcomes. We will assess chil-
dren with and without ADHD as they progress through
puberty at mean ages 10, 11.5 and 13 years. This design
will enable us to map trajectories in brain growth and
how they differ between typically developing children
and those with ADHD. We will be able to ascertain
whether such changes are reflected in ADHD symptom-
atology and functional abilities.
Study aims
The primary aims are to 1) Describe how brain structure
(whole-brain volume, grey-matter volume, white-matter
volume, cortical thickness, diffusion indices) and function
(resting state connectivity) change across late childhood to
early adolescence (brain growth trajectories) for children
with and without ADHD; and 2) Examine whether differ-
ences in trajectories of brain structure and function reflect
differential outcomes for children with ADHD and non-
ADHD controls. Outcomes to be assessed include the per-
sistence of ADHD, ADHD symptom severity and functional
outcomes (academic, cognitive, social, and mental health).
Secondary aims will explore the impact of sex, ADHD
presentation, ADHD severity, comorbidities and medica-
tion use on brain growth trajectories.
Methods/Design
NICAP is single site, multimodal neuroimaging study in a
community-based cohort of children with and without
ADHD conducted longitudinally over a 5-year period. Base-
line, 18 and 36 month follow-ups will be conducted be-
tween 2014 and 2018. The study is funded by the
Australian National Medical Health and Research Council
(NHMRC; project grant #1065895). Ethics approval was
granted by the Royal Children’s Hospital Human Research
Ethics Committee, Melbourne (#34071).
The cohort
CAP (2011–2015)
Participants for NICAP are recruited from the CAP. The
CAP cohort and methods have been described previously
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[8]. Briefly, children were screened for ADHD using both
parent and teacher reports on the Conners 3 [30] ADHD
Index (N = 6098) in their second year of formal schooling.
Surveys were distributed across 43 socio-economically di-
verse Melbourne primary schools. Children screened posi-
tive as potential ADHD cases (both the parent and
teacher ADHD indices were ≥75th percentile for age for
boys, and ≥80th percentile for girls) and a matched sample
of those screened negative (both parent and teacher
ADHD indices were <75th percentile for boys and <80th
percentile for girls) received a parent face-to-face diagnos-
tic interview to confirm diagnostic status. Baseline data
were collected between 2011 and 2012, for a sample of
179 children with confirmed ADHD and 212 confirmed
non-ADHD controls aged 7 years. Participants were
followed up at two 18 month intervals at ages 8.5 and
10 years.
NICAP (2014–2018)
Recruitment for NICAP participation coincides with the
CAP 36 month data collection (age 10 years). Parents
provide additional written informed consent for the
NICAP study. Approximately 100 ADHD and 100 typic-
ally developing controls will be recruited for NICAP
baseline assessment. Two follow-up assessments will
occur at 18-month intervals when participants are aged
11.5 and 13 years.
Power and sample size
Our sample size is primarily based on the feasibility of
recruitment from the pre-existing CAP cohort. Based on
recruitment of equal numbers of controls to ADHD
cases, with a participation rate of 65 %, accounting for
exclusions due to MRI incompatibility (e.g., dental
braces), and an estimated attrition of 5 % at each time-
point, we expect ~100, 95 and 90 participants per group
at timepoints 1, 2 and 3 respectively. It is difficult to es-
timate with precision the power this will provide for de-
tecting group differences in trajectories of development.
However, a study of the sample size required in longitu-
dinal MRI studies of brain volume in adults [31] sug-
gests 80 % power detection of a 5 % difference between
two groups for change in even small subcortical struc-
tures (e.g., the caudate) from a sample size of 90–104
per group.
Procedure
At each data collection time-point participating families will
attend a 3.5 h assessment session at The Royal Children’s
Hospital, Melbourne, Australia. Assessment sessions in-
volve a structured diagnostic interview, parent question-
naire, child cognitive assessment and MRI scanning. Saliva
samples will also be collected for future research
questions around genetics and pubertal hormones.
With parent consent, questionnaires will be sent to the
child’s classroom teacher.
Measures are summarized in Table 1. Children will be
assessed in their usual classroom condition, therefore, if
the child is currently using medication, they are not
asked to cease medication for the assessment, but details
of medication history and dosage are recorded. Research
staff conducting assessments will be blinded to the
child’s diagnostic status.
Measures
Diagnostic interview
NIMH Diagnostic Interview Schedule for Children-IV
[32]: At baseline (10 years) and 36 months (13 years),
parents complete the well-validated and widely used
DISC-IV diagnostic interview (60–90 mins) to determine
the participants’ ADHD status and comorbid mental
health problems including anxiety, mood and externaliz-
ing disorders.
Questionnaires
Questionnaires assess several domains covering a range
of predictors and outcome variables. Key measures are
described below and summarized in Table 1. Parent and
teachers complete questionnaires pertaining to the
child’s ADHD symptom severity and their social and
emotional functioning. Parents also complete a series of
questionnaires about the child’s functioning including
emotional, physical, social and school quality of life, the
child’s peer victimization, a screening measure for aut-
ism spectrum disorder symptoms, the child’s general
health, the use of allied health services and medication
history. Questionnaires concerning the home environ-
ment include a measure of family quality of life, stressful
life events, and parents’ mental health. Numerous scales
are drawn from the Longitudinal Study of Australian
Children (LSAC; [33]) with items assessing parenting
and the parent couple relationship. Retrospective ques-
tions regarding potentially relevant pre- and post-natal
factors are also assessed, such as maternal alcohol use
and smoking during pregnancy, gestational diabetes, pre-
clampsia, stress/anxiety/depression/stressful life events
during pregnancy, birth weight, gestational age, intensive
care following birth and maternal postnatal depression.
Teachers are asked questions around the child’s aca-
demic competence, the student-teacher relationship, as
well as details on the teacher characteristics and educa-
tion services. Those not described below have been de-
scribed in detail elsewhere [8].
Pubertal development
The Pubertal Development Scale (PDS) [34] is a parent-
reported measure assessing development on five indices
of pubertal growth. Parents are asked about whether the
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Table 1 Summary of assessment measures for NICAP
Measures Source Timepoint
CAP NICAP
1 2 1 2 3
Diagnostic Interview
ADHD & comorbidities DISC-IV; structured clinical interview [32] P • • •
Magnetic Resonance Imaging
Structural T1 C • • •
Structural T2 C • • •
Multishell DWI C • • •
Resting state fMRI C • • •
Quantitative susceptibility mapping C • • •
Cognitive Assessment
Intellectual functioning WASI: vocabulary, matrix reasoning [52] C • • • •
Language CELF 4th edition: screening test [53] C • • • •
Academic achievement WRAT 4: word reading, numeracy [54] C • • • •
Working memory Computerised spatial n-back C • • •
Inhibition Computerised Stop-signal task C • • •
Sustained attention Computerised SART C • • •
Spatial attention Landmark task C • • •
Cognitive flexibility Computerised set-shifting task C • • •
Visual-motor Grooved pegboard test C • • •
Questionnaires
Puberty development Pubertal development scale; Tanner stage charts P • • •
Child functioning
ADHD symptoms Conner’ 3 parent & teacher ADHD index [30] P, T • • • • •
Autism Spectrum Disorder SCQ - Lifetime version [55]; SSIS: Autism spectrum scale [56] P • • • • •
Mental health & social functioning SDQ: Total problems score, emotional, conduct, peer and
inattention-hyperactivity scale [57]
P, T • • • • •
Social Skills SSIS: Responsibility, self-control, bullying, communication
and engagement scales [56]
P, T • • • • •
Prosocial behaviours SDQ: Prosocial behaviour [57] P, T • • • • •
Victimisation SEQ: Physical victimisation, relational victimisation [58] P • • • •
Quality of Life Pediatric quality of life inventory (Peds QL v4) [59] P • • • • •
Health Medication history, child global health, sustained injuries,
allied health services use
P • • • • •
Home environment
Parental mental health Kessler 6 (K6): psychosocial symptom screener [60] P • • • • •
Family quality of life CHQ: Emotional impact, time impact, family activities [61] P • • • • •
Family adversity Stressful life events scale [62] P • • • • •
Parenting LSAC parenting scales: parental warmth, hostility, consistency,
parental self-efficacy [63]
P • • • • •
Couple relationship LSAC family functioning scales: parental conflict, support,
and relationship satisfaction [63]
P • • • • •
Pre/postnatal factors LSAC prenatal & postnatal questions P •
School environment
Classroom performance SSIS: Academic competence [56] T • • • •
Teacher-child relationship STRS (short form): conflict and closeness [64] T • • • •
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child’s secondary sexual characteristics have 1) not yet
started, 2) barely started, 3) definitely started, 4) seems
complete. Parents of males are asked about changes to
voice and growth of facial hair and parents of females
are asked about breast development and about the onset
and age of menstruation.
The Tanner Sexual Maturation Scale (SMS) is a
parent-reported measure used to assess the child’s pu-
bertal stage. It comprises drawings of five progressive
stages of pubertal development of secondary sexual
characteristics, from stage 1 (pre-adolescent) through to
stage 5 (adult appearance). For males, five drawings
combining pubic hair and genital development are pre-
sented. For females, breast development and pubic hair
development are presented in different drawings. Tanner
staging has historically been considered the gold stand-
ard for puberty measurement [35].
Cognitive assessment
NICAP includes direct assessments of working mem-
ory, inhibition, sustained attention, cognitive flexibil-
ity, spatial attention and visuo-motor integration. The
first four tasks are computer-based, enabling measure-
ment of properties such as reaction time.
The Stop Signal Task assesses response inhibition [36].
Subjects perform a choice reaction task and on a ran-
dom selection of the trials, an auditory stop signal in-
structs subjects to withhold their response.
The Sustained Attention to Response Task (SART) is a
measure of sustained attention [37]. The fixed version of
SART is a repeating sequence of digits (1–9). Using a
button press, participants respond to every digit (go-
trial) except ‘3’ (no-go trial).
The Spatial N-Back is a widely used measure of
working memory that requires flexible updating cap-
abilities. This includes a spatial 1-back and 2-back
version. The 1-back requires maintaining and updat-
ing one location at a time, whereas the more diffi-
cult 2-back requires maintaining and updating two
locations.
The Set Shifting task assesses cognitive flexibility. Two
target pictures are presented that vary along two dimen-
sions (e.g., shape and color). Participants are cued with a
letter to respond to the target pictures, according to one
dimension.
The Landmark Task is a paper-based task measuring
spatial attention [38]. Participants are presented with 20
examples of a bisected line, half are bisected exactly in
the middle, while the remainder are bisected slightly off-
set to the left or right. Participants indicate which side
of the line is shorter. Leftward or rightward spatial biases
can be ascertained.
The Grooved Pegboard test (Lafayette Instruments,
Lafayette, IN) is a timed motor test to assess complex
visual-motor coordination for both the dominant and
non-dominant hand. Participants place grooved pegs
into a pegboard unit in an ordered pattern of 25 holes,
requiring the participant to match the groove of the peg
with the groove of the board.
Neuroimaging procedure
Mock scanner training
Children complete a 30 min training session in a mock
MRI scanner which reproduces the physical environ-
ment of the real scanner including sound recording of
the scanner noises. This familiarizes participants to the
MRI environment, lowers anxiety and provides practice
at keeping still during the scanning session.
MRI scan
Neuroimaging data are collected from a single-site on a
research-dedicated 3-Tesla Siemens TIM Trio MRI scan-
ner (Siemens, Erlangen, Germany) at the Murdoch Chil-
drens Research Institute, The Royal Children’s Hospital,
Melbourne. Using a 32-channel head coil, the multi-
modal MRI acquisition techniques have been selected to
provide advanced information concerning the structural
and functional development of the brain and regional
development of specific structures. The neuroimaging
protocol comprises structural and functional sequences
Table 1 Summary of assessment measures for NICAP (Continued)
Teacher characteristics Including teacher age, gender, teaching experience,
education, self-efficacy, from LSAC; level of support.
T • • • •
Education services Specialised school services, individual education plans,
in-class assistance and grade repetition.
T • • • •
Physical Measures
Height, weight C • • • •
Saliva C • • •
Child ages for data collection timepoints are 7 years (CAP 1), 8.5 years (CAP 2) 10 year (NICAP 1), 11.5 years (NICAP 2) and 13 years (NICAP 3)
Abbreviations: CELF Clinical evaluation of language fundamentals, CHQ child health questionnaire, DISC-IV diagnostic interview schedule for children-IV, DWI diffusion
weighted imaging, fMRI functional magnetic resonance imaging, LSAC longitudinal study of Australian children, SART sustained attention to response task, SCQ social
comnmunication questionnaire SDQ strengths & difficulties questionnaire, SEQ social experience questionnaire, SSIS social skills improvement system; STRS student-
teacher relationship scale, TEA-CH test of everyday attention for children, WASI Wechsler abbreviated scales of intelligence, WISC Wechsler intelligence scale for children,
WRAT wide range achievement test
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lasting approximately 45mins. See Fig. 1 and Table 2 for
sequence details.
Structural imaging
A modified multi-echo magnetization prepared rapid
gradient-echo (MEMPRAGE) sequence, incorporating
navigator based prospective motion correction, will be
acquired to provide T1-weighted anatomical images
[39, 40]. The MEMPRAGE sequence has many of the
properties of a traditional MPRAGE sequence of distin-
guishing grey matter and white matter morphometry. The
sequence averages multiple high bandwidth acquisitions
reducing susceptibility artifacts and improving the con-
trast of the dura and subcortical structures, allowing for
more accurate tissue segmentation.
We also employ Siemens in-scanner motion correction
(MoCo) in which the field-of-view/slice positioning is
updated in real time to accommodate for motion during
the acquisition. This reduces motion artifact and dra-
matically improves image quality. This is particularly im-
portant in this population of children with attentional
and hyperactivity difficulties, as motion artifact is a large
challenge.
Additional morphometric information is obtained by
employing the T2-SPACE (Sampling Perfection with Ap-
plication optimized Contrast with flip angle Evolution)
protocol to provide T2-weighted anatomical images.
Together, the MEMPRAGE and T2-SPACE provides T1-
weighted and T2-weighted volumes providing optimal
sensitivity for tracking subtle changes in cortical
morphometry.
Multi-band, multi-shell diffusion MRI
Diffusion-weighted images (DWI) are acquired to probe
white matter microstructure. Multi-band accelerated EPI
sequences protocol, developed by the Centre for Mag-
netic Resonance Research (CMRR, University of Minne-
sota), are acquired in order to accelerate DWI volume
coverage allowing multiple shell acquisition. Three shells
are acquired using this protocol (b = 2800, 2000, 1000 s/
mm2 + interleaved b = 0 s/mm2) with an anterior-
posterior phase encoding direction. Standard and reverse
phase encoded blipped image with no diffusion weight-
ing (Blip Up and Blip Down) are also acquired to correct
for magnetic susceptibility-induced distortions related to
the EPI acquisitions [41, 42].
Images are acquired with a multi-band acceleration fac-
tor of three. The advantage of using multi-band acceler-
ated imaging is the reduced acquisition time, which allows
the collection of multiple diffusion weightings (see Table 2)
in the time it takes to collect just one typical diffusion
weighting without multi-band acceleration. By acquiring
three diffusion-weighted shells, we can obtain high angu-
lar resolution diffusion imaging (HARDI) required for
spherical deconvolution tractography, as well as high
signal-to-noise ratio (SNR) data for reliably assessing
quantitative scalar metrics in white matter microstructure.
The DW processing pipeline uses a combination of
purpose built neuroimaging tools from the MRtrix [43]
and FSL [44] packages. First, raw images are corrected
for susceptibility-induced geometric distortions, eddy
current distortions, and inter-volume subject motion
using EDDY and TOPUP toolboxes [45]. Corrected im-
ages then have all non-brain material “stripped” away by
Fig. 1 An example of the different sequences acquired to evaluate structural and functional development (a) T1-weighted; (b) T2-weighted; (c)
Quantitative Susceptibility Mapping; (d) Diffusion Weight Imaging: fractional anisotropy (FA) map; (e) Diffusion Weight Imaging: estimation of the
fibre orientation distribution; (f) Diffusion Weight Imaging: whole brain tractography; (g) resting state fMRI showing default mode network; (h)
connectivity network for structural and function connectivity
Silk et al. BMC Psychiatry  (2016) 16:59 Page 6 of 9
the BET tool [46]. For low b-value images, the diffusion
tensors are calculated and scalar maps generated. For
high b-value data, the images are prepared for con-
strained spherical deconvolution (CSD) tractography by:
the estimation of a response function; estimation of the
fibre orientation distribution (FOD); anatomically con-
strained tractography (ACT) in the white matter [47];
and SIFT2 to reconstruct streamline densities that are
proportional to the fibre densities [48].
Multi-band resting state functional MRI
Resting state fMRI (rs-fMRI) images are acquired to
measure spontaneous intrinsic correlated neural activity
while subjects are at rest, enabling detection of func-
tional connectivity between brain regions. rs-fMRI has
longitudinal reliability and reproducibility in children
[49], has the advantaged of not relying on task compli-
ance, and avoids issues of age-appropriateness of task in
longitudinal studies. Participants are instructed to keep
eyes open and to look at a fixation cross. The multi-
band accelerated EPI sequences (MB3), acquired as
above, allows for 250 volumes with whole brain coverage
to be acquired in a 6 min 33 s sequence.
The rs-fMRI processing pipeline begins with realign-
ment of EPI volumes to correct for participant movement.
Volumes are then aligned to the participant’s structural
images, which are segmented into different tissue classes.
Removal of physiological noise and other nuisance
variables is then performed using a component-based
approach. Signal from white matter and cerebrospinal
fluid is used to estimate noise of non-neuronal origin (e.g.,
cardiac, respiratory). This noise is then removed from re-
gions of interest, along with the contribution of realign-
ment parameters and movement outliers.
Quantitative susceptibility mapping (QSM)
QSM provides a quantitative and spatially specific image
contrast, which is differentially sensitive to myelin and
iron content [50]. The novel sequence used in this study
is a multi-echo spoiled-gradient-recalled (SPGR) se-
quence. We have optimized the acquisition protocol to
reduce acquisition time to 8 min and 43 s, which is
more feasible for a pediatric population. The QSM and
phase reconstruction algorithm [51] are employed to
process and analyze the data.
Quality control
Quality control procedures are important at a number of
steps. Regarding MRI motion artifacts, several steps are
taken in order to minimize movement during the scanning
and to assess the data quality afterwards. The mock scan-
ner session prior to the scan is vital to assist participants
be aware of movements and become comfortable in the
scanner environment. During all scans except for the rs-
fMRI participants watch a movie of their choice distracting
them from the scanning environment. During scanning,
movement is monitored and participants are reminded to
keep still when necessary. Poor images due to motion are
Table 2 MRI sequence parameters for scanning
Sequence T1w T2w DWI fMRI QSM
Type MEMPRAGE T2-SPACE Shell 1 Shell 2 Shell 3 Blip Up/Down rs-fMRI Blip Up/Down Multi-echo
TR (ms) 2530 3200 3200 3200 3200 3200 1500 3980 52
TE (ms) 1.77, 3.51
5.32, 7.2
532 110 110 110 110 33 33 7.38, 14.76, 22.14,
29.52, 36.90, 44.27
TI (ms) 1260 - - - - - - - -
Flip angle (deg) 7 - 90 90 90 90 85 85 15
Slices 176 176 63 63 63 63 60 60 -
Voxel size (mm3) 0.9 0.9 2.4 2.4 2.4 2.4 2.5 2.5 1.0
FoV read (mm) 230 240 260 260 260 260 255 255 256
FoV phase (%) 90.6 89.8 100 100 100 100 100 100 68.8
Matrix 256 × 232 256 × 230 110 × 110 110 × 110 110 × 110 110 × 110 104 × 104 104 × 104 256 × 176
Band width (Hz/Px) 723, 751,
651, 651
610 1748 1748 1748 1748 1718 1718 210, 210, 210, 210,
210, 210
Echo spacing (ms) 10.1 3.76 0.69 0.69 0.69 0.69 0.69 0.69 -
Orientation S S T T T T T T T
B value (s/mm2) - - 2800 2000 1000 0 - - -
No. directions/b = 0 s - - 60/4 45/6 25/6 -/2 - - -
Multi-band factor - - 3 3 3 3 3 1 -
Acquisition time 6 m 52 s 4 m 8 s 3 m 57 s 3 m 15 s 2 m 11 35 s (x 2) 6 m 33 s 24 s (x 2) 8 m 43 s
S sagittal, T transversal
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repeated if time permits. At the scanner level, scanner
stability is monitored weekly with the standard functional
Brain Imaging Research Network (FBIRN) QA protocol.
In addition, T1 and T2 are performed to examine signal-
to-noise and image uniformity.
Staff training and supervision
Research staff and students who conduct the assess-
ments are trained to a high level of competence in the
scanning and assessment procedures, and are observed
for the first two assessments. Written standard operation
procedures were developed for standardized assess-
ments, cognitive testing, mock scan and saliva collection.
Fortnightly supervision meetings take place with a regis-
tered clinical psychologist (ES) in order to maintain
consistency across cognitive and diagnostic assessments.
Discussion
This research will provide the ability to map trajectories
of brain structure and function onto a comprehensive
set of functional outcome domains encompassing aca-
demic, cognitive, social, and mental health functioning.
Developing a large database of multimodal MRI se-
quences with ongoing clinical and cognitive/behavioral
measures in a demographically diverse sample will en-
able the detection of subtle, yet important, differences in
brain developmental trajectories in children with ADHD
compared to non-ADHD peers.
Identifying objective neural markers of outcomes in
ADHD, and potential modifiable predictors of outcomes
will be an important innovation and will contribute sub-
stantially to improving the prognosis of children with
ADHD. Establishing which brain regions are associated
with positive clinical outcomes will help improve predic-
tions about the course of ADHD. The advantage of a
large community sample is the opportunity to examine
neurobiological development across the continuum of
severity, as well as in healthy controls.
A better understanding of the developmental links be-
tween brain changes and outcomes also has important
implications for children with developmental and mental
health problems broader than ADHD. The identification
of neurodevelopmental changes associated with func-
tional outcomes will open the possibility for future stud-
ies to test targeted interventions leading to improved
long-term outcomes.
Competing interests
PH’s institution has received payment from Eli Lilly and Janssen for consultancies;
Eli Lilly, Janssen, Novartis and Shire for advisory boards; Eli Lilly, Janssen, Pfizer and
Shire for speaker’s bureau; Eli Lilly and Celltech for the conduct of clinical trials. All
authors declare that they have no competing interests.
Authors’ contributions
TS, VA, ES, JN, DE, and PH contributed to the overall design and conceptualization
of the study and assisted with the writing of the grant application and revised this
manuscript. TS, ES, SG and CM contributed to study implementation.
MK assisted in developing and optimizing the neuroimaging sequence
parameters. All authors read and approved the final manuscript.
Acknowledgements
We would like to thank all of the many families and schools for their
participation in this study. We would also like to acknowledge all staff and
students for their contribution to this study, and Amanda Ng’s contribution
to the development of the QSM sequence. The study was funded by the
National Medical Health and Research Council of Australia (NHMRC; project
grant #1065895). The Children’s Attention Project was as funded by an
NHMRC project grant #1008522 and a grant from the Collier Foundation. The
research was supported by the Murdoch Childrens Research Institute, The
Royal Children’s Hospital, The Royal Children’s Hospital Foundation,
Department of Paediatrics at The University of Melbourne and the Victorian
Government's Operational Infrastructure Support Program. ES was supported
by NHMRC Early Career (1037159) and Career Development (1110688)
Fellowships. TS was supported by an NHMRC Career Development Award
(1004637). VA was supported by an NHMRC Senior Practitioner Fellowship
(1079478). JN was funded by the Australian Communities Foundation
through the Roberta Holmes Chair for the Transition to Contemporary
Parenthood Program (Coronella sub-fund).
Author details
1Murdoch Childrens Research Institute, Melbourne, Australia. 2The Royal
Children’s Hospital, Melbourne, Australia. 3Department of Paediatrics,
University of Melbourne, Melbourne, Australia. 4Discipline of Psychiatry,
University of Sydney, Sydney, Australia. 5Judith Lumley Centre, La Trobe
University, Melbourne, Australia. 6School of Psychology, Deakin University,
Melbourne, Australia.
Received: 3 February 2016 Accepted: 3 March 2016
References
1. Polanczyk GV, Salum GA, Kieling C, Rohde LA, Willcutt EG. ADHD prevalence
estimates across three decades: an updated systematic review and meta-
regression analysis. Int J Epidemiol. 2014;43:434–42.
2. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention
deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol
Med. 2006;36:159–65.
3. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, et al.
Young adult outcome of attention deficit hyperactivity disorder: a
controlled 10-year follow-up study. Psychol Med. 2006;36:167–79.
4. Wilens TE, Biederman J, Brown S, Tanguay S, Monuteaux MC, Blake C, et al.
Psychiatric comorbidity and functioning in clinically referred preschool
children and school-age youths with ADHD. J Am Acad Child Adolesc
Psychiatry. 2002;41:262–8.
5. Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry.
2006;67 Suppl 8:27–31.
6. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, Addalli KA.
Hyperactive boys almost grown up. V. Replication of psychiatric status.
Arch Gen Psychiatry. 1991;48:77–83.
7. Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/
hyperactivity disorder in children and adolescents. Ambul Pediatr.
2007;7:121–31.
8. Sciberras E, Efron D, Schilpzand EJ, Anderson V, Jongeling B, Hazell P, et al.
The Children's Attention Project: a community-based longitudinal study of
children with ADHD and non-ADHD controls. BMC Psychiatry. 2013;13:18.
9. Langberg JM, Epstein JN, Altaye M, Molina BSG, Arnold LE, Vitiello B. The
transition to middle school is associated with changes in the
developmental trajectory of ADHD symptomatology in young adolescents
with ADHD. J Clin Child Adolesc Psychol. 2008;37:651–63.
10. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of
attention deficit hyperactivity disorder: impact of remission definition and
symptom type. Am J Psychiatry. 2000;157:816–8.
11. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in
attention-deficit hyperactivity disorder in boys: a four-year longitudinal
study. J Abnorm Child Psychol. 1995;23:729–49.
Silk et al. BMC Psychiatry  (2016) 16:59 Page 8 of 9
12. Fischer M, Barkley RA, Fletcher KE, Smallish L. The stability of dimensions of
behavior in ADHD and normal children over an 8-year followup. J Abnorm
Child Psychol. 1993;21:315–37.
13. Barkley RA, Fischer M, Edelbrock CS, Smallish L. The adolescent outcome of
hyperactive children diagnosed by research criteria: I. An 8-year prospective
follow-up study. J Am Acad Child Adolesc Psychiatry. 1990;29:546–57.
14. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C. Diagnostic
continuity between child and adolescent ADHD: findings from a longitudinal
clinical sample. J Am Acad Child Adolesc Psychiatry. 1998;37:305–13.
15. King JA, Tenney J, Rossi V, Colamussi L, Burdick S. Neural Substrates
Underlying Impulsivity. Ann N Y Acad Sci. 2003;1008:160–9.
16. Konrad K, Neufang S, Hanisch C, Fink GR, Herpertz-Dahlmann B.
Dysfunctional attentional networks in children with attention deficit/
hyperactivity disorder: evidence from an event-related functional magnetic
resonance imaging study. Biol Psychiatry. 2006;59:643–51.
17. Rubia K, Smith AB, Woolley J, Nosarti C, Heyman I, Taylor E, et al. Progressive
increase of frontostriatal brain activation from childhood to adulthood during
event related tasks of cognitive control. Hum Brain Mapp. 2006;27:973–93.
18. Schulz KP, Newcorn JH, Fan J, Tang CY, Halperin JM. Brain activation
gradients in ventrolateral prefrontal cortex related to persistence of ADHD
in adolescent boys. J Am Acad Child Adolesc Psychiatry. 2005;44:47–54.
19. Silk T, Vance A, Rinehart N, Egan G, O’Boyle M, Bradshaw JL, et al. Fronto-
parietal activation in attention-deficit hyperactivity disorder, combined type:
functional magnetic resonance imaging study. Br J Psychiatry. 2005;187:282–3.
20. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al.
Developmental trajectories of brain volume abnormalities in children and
adolescents with attention-deficit/hyperactivity disorder. JAMA. 2002;288:1740–8.
21. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP,
et al. Quantitative brain magnetic resonance imaging in attention-deficit
hyperactivity disorder. Arch Gen Psychiatry. 1996;53:607–16.
22. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D, et al.
Quantitative morphology of the caudate nucleus in attention deficit
hyperactivity disorder. Am J Psychiatry. 1994;151:1791–6.
23. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN,
Biederman J. Volumetric MRI analysis comparing subjects having attention-
deficit hyperactivity disorder with normal controls. Neurology. 1997;48:589–601.
24. Giedd JN, Castellanos FX, Casey BJ, Kozuch P, King AC, Hamburger SD, et al.
Quantitative morphology of the corpus-callosum in attention-deficit
hyperactivity disorder. Am J Psychiatry. 1994;151:665–9.
25. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D. Brain
morphology in developmental dyslexia and attention deficit disorder/
hyperactivity. Arch Neurol. 1990;47:919–26.
26. Mostofsky SH, Reiss AL, Lockhart P, Denckla MB. Evaluation of cerebellar size
in attention-deficit hyperactivity disorder. J Child Neurol. 1998;13:434–9.
27. Sowell ER, Thompson PM, Welcome SE, Henkenius AL, Toga AW, Peterson BS.
Cortical abnormalities in children and adolescents with attention-deficit
hyperactivity disorder. Lancet. 2003;362:1699–707.
28. El-Sayed E, Larsson JO, Persson HE, Santosh PJ, Rydelius PA. “Maturational
lag” hypothesis of attention deficit hyperactivity disorder: an update. Acta
Paediatr. 2003;92:776–84.
29. Frodl T, Skokauskas N. Meta analysis of structural MRI studies in children and
adults with attention deficit hyperactivity disorder indicates treatment
effects. Acta Psychiatr Scand. 2012;125:114–26.
30. Conners CK. Conners 3rd Edition. Toronto: Multi-Health Systems; 2008.
31. Steen RG, Hamer RM, Lieberman JA. Measuring brain volume by MR
imaging: Impact of measurement precision and natural variation on sample
size requirements. AJNR Am J Neuroradiol. 2007;28:1119–25.
32. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH
Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV):
description, differences from previous versions, and reliability of some
common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39:28–38.
33. Nicholson JM, Sanson A. A new longitudinal study of the health and wellbeing
of Australian children: how will it help? Med J Aust. 2003;178:282–4.
34. Petersen AC, Crockett L, Richards M, Boxer A. A self-report measure of pubertal
status: Reliability, validity, and initial norms. J Youth Adolesc. 1988;17:117–33.
35. Dorn LD. Measuring Puberty. J Adolesc Health. 2006;39(5):625–6.
36. Verbruggen F, Logan GD, Stevens MA. STOP-IT: Windows executable
software for the stop-signal paradigm. Behav Res Methods. 2008;40:479–83.
37. Robertson IH, Manly T, Andrade J, Baddeley BT, Yiend J. “Oops!”:
performance correlates of everyday attentional failures in traumatic brain
injured and normal subjects. Neuropsychologia. 1997;35:747–58.
38. Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH.
Association between dopamine transporter (DAT1) genotype, left-sided
inattention, and an enhanced response to methylphenidate in attention-
deficit hyperactivity disorder. Neuropsychopharmacology. 2005;30:2290–7.
39. Tisdall MD, Hess AT, Reuter M, Meintjes EM, Fischl B, van der Kouwe AJW.
Volumetric navigators for prospective motion correction and selective
reacquisition in neuroanatomical MRI. Magn Reson Med. 2012;68:389–99.
40. van der Kouwe AJW, Benner T, Salat DH, Fischl B. Brain morphometry with
multiecho MPRAGE. Neuroimage. 2008;40:559–69.
41. Auerbach EJ, Xu J, Yacoub E, Moeller S, Uğurbil K. Multiband accelerated
spin echo echo planar imaging with reduced peak RF power using time
shifted RF pulses. Magn Reson Med. 2013;69:1261–7.
42. Xu J, Moeller S, Auerbach EJ, Strupp J, Smith SM, Feinberg DA, et al.
Evaluation of slice accelerations using multiband echo planar imaging at
3 T. Neuroimage. 2013;83:991–1001.
43. Tournier J-D, Calamante F, Connelly A. MRtrix: Diffusion tractography in
crossing fiber regions. Int J Imaging Syst Technol. 2012;22:53–66.
44. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ,
Johansen-Berg H, et al. Advances in functional and structural MR image
analysis and implementation as FSL. Neuroimage. 2004;23:S208–19.
45. Andersson JLR, Sotiropoulos SN. An integrated approach to correction for
off-resonance effects and subject movement in diffusion MR imaging.
Neuroimage. 2016;125:1063–78.
46. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp.
2002;17:143–55.
47. Smith RE, Tournier JD, Calamante F, Connelly A. Anatomically-constrained
tractography: improved diffusion MRI streamlines tractography through
effective use of anatomical information. Neuroimage. 2012;62:1924–38.
48. Smith RE, Tournier JD, Calamante F, Connelly A. SIFT2: Enabling dense
quantitative assessment of brain white matter connectivity using
streamlines tractography. Neuroimage. 2015;119:338–51.
49. Thomason ME, Dennis EL, Joshi AA, Joshi SH, Dinov ID, Chang C, et al.
Resting-state fMRI can reliably map neural networks in children.
Neuroimage. 2011;55:165–75.
50. Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E, et al.
Quantitative susceptibility mapping (QSM) as a means to measure brain iron?
A post mortem validation study. Neuroimage. 2012;62:1593–9.
51. Li W, Wang N, Yu F, Han H, Cao W, Romero R, et al. A method for
estimating and removing streaking artifacts in quantitative susceptibility
mapping. Neuroimage. 2015;108:111–22.
52. Wechsler D. Wechsler Intelligence Scale for of Intelligence (WASI). San
Antonio: Harcourt; 1999.
53. Semel E, Wiig E, Secord W. Clinical Evaluation of Language Fundamentals-
Screening Test Australian & New Zealand Language Adapted Edition
(CELF-4 Screener). Sydney: NCS Pearson; 2004.
54. Wilkinson GS, Robertson GJ. Wide Range Achievement Test (WRAT4). Lutz:
Psychological Assessment Resources; 2006.
55. Rutter M, Bailey A, Lord C. SCQ: Social Communication Questionnaire.
Los Angeles: Western Psychological Services; 2003.
56. Gresham FM, Elliott SN, Kettler RJ. Base rates of social skills acquisition/
performance deficits, strengths, and problem behaviors: an analysis of the Social
Skills Improvement System–Rating Scales. Psychol Assess. 2010;22:809–15.
57. Hawes DJ, Dadds MR. Australian data and psychometric properties of the
Strengths and Difficulties Questionnaire. Aust N Z J Psychiatry. 2004;38:644–51.
58. Crick NR, Grotpeter JK. Children’s treatment by peers: targets of relational
and overt aggression, Development and psychopathology. 1996.
59. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric
population health measure: feasibility, reliability, and validity. Ambul Pediatr.
2003;3:329–41.
60. Furukawa TA, Kessler RC, Slade T, Andrews G. The performance of the K6 and
K10 screening scales for psychological distress in the Australian National
Survey of Mental Health and Well-Being. Psychol Med. 2003;33:357–62.
61. Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): a user’s
manual. Boston: The Health Institute, New England Medical Center; 1996.
62. Brugha TS, Cragg D. The list of threatening experiences: the reliability and
validity of a brief life events questionnaire. Acta Psychiatr Scand. 1990;82:77–81.
63. Zubrick SR, Smith GJ, Nicholson J, Sanson A, Jackiewicz TA. Parenting and
families in Australia. Social policy reseach paper No. 34. Canberra: Department
of Families, Housing, Community Service and Indigenous Affairs; 2008.
64. Pianta RC. STRS: student-teacher relationship scale: professional manual.
Odessa: Psychological Assessment Resources; 2001.
Silk et al. BMC Psychiatry  (2016) 16:59 Page 9 of 9
